Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | MITF | O75030 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | SCN4A | P35499 | 1/20 | 0.57 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.57 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.57 |
| ▸ | BCHE | P06276 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182096 | 1.00 | ALDH1A1 (0.62) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 | |
| SCHEMBL3296716 | 0.82 | TSHR (0.71) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 | |
| SCHEMBL11111811 | 0.82 | KDM4E (0.47) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 | |
| SCHEMBL11117755 | 0.81 | KDM4E (0.47) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 | |
| SCHEMBL4702616 | 0.79 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 | |
| SCHEMBL11548268 | 0.79 | KDM4E (0.67) | ALDH1A1MEN1KMT2AKDM4ENPC1 | |
| SCHEMBL4221958 | 0.79 | NPC1 (0.65) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 | |
| SCHEMBL11641398 | 0.79 | MEN1 (0.50) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 | |
| SCHEMBL31182095 | 0.79 | KDM4E (0.67) | ALDH1A1MEN1KMT2AKDM4ENPC1 | |
| SCHEMBL8257409 | 0.79 | NPC1 (0.69) | ALDH1A1MEN1KMT2AKDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111285805-A | Preparation method of oxcarbazepine | 重庆圣华曦药业股份有限公司 | 2020-06-16 | — | — | CN | claimed |
| EP-0108715-A1 | Dibenzazepine carboxamides | CIBA-GEIGY AG (CH) | 1984-05-16 | — | — | EP | claimed |
| JP-7061930-A | — | — | None | — | — | JP | disclosed |
| CN-118878463-A | Method for synthesizing oxcarbazepine or intermediate thereof | 浙江工业大学 | 2024-11-01 | — | — | CN | disclosed |
| US-20230129254-A1 | METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE | BIAL PORTELA & CA SA (PT) | 2023-04-27 | — | — | US | disclosed |
| US-11364247-B2 | Methods of treatment of partial onset seizures using eslicarbazepine acetate | BIAL-PORTELA & CA S.A. (PT) | 2022-06-21 | — | — | US | disclosed |
| US-20210154203-A1 | METHODS OF TREATMENT OF PARTIAL ONSET SEIZURES USING ESLICARBAZEPINE ACETATE | BIAL-PORTELIA & CA, S.A. (PT) | 2021-05-27 | — | — | US | disclosed |
| WO-2021073231-A1 | PREPARATION METHOD FOR ESLICARBAZEPINE | 浙江九洲药业股份有限公司 | 2021-04-22 | — | — | WO | disclosed |
| EP-3680233-A1 | NOVEL AMIDE COMPOUND, AND Pin1 INHIBITOR, THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES AND THERAPEUTIC AGENT FOR CANCER THAT USE THE SAME | Hiroshima University (JP) | 2020-07-15 | — | — | EP | disclosed |
| US-10702536-B2 | Methods of treatment of partial onset seizures using eslicarbazepine acetate | BIAL-PORTELA & CA S.A. (PT) | 2020-07-07 | — | — | US | disclosed |
| US-10695354-B2 | Methods of treatment of partial onset seizures using eslicarbazepine acetate | BIAL-PORTELA & CA S.A. (PT) | 2020-06-30 | — | — | US | disclosed |
| EP-1004566-A2 | Process for oxidation of substrates containing methyl, methylene or methin groups | DSM Fine Chemicals Austria GmbH (AT) | 2000-05-31 | — | — | EP | disclosed |
| US-5665543-A | Method of discovering chemicals capable of functioning as gene expression modulators | ONCOGENE SCIENCE, INC. (US) | 1997-09-09 | — | — | US | disclosed |
| JP-H0761930-A | INHIBITOR OF CANCER METASTASIS | NIPPON ZEON CO LTD | 1995-03-07 | — | — | JP | disclosed |
| EP-0483249-A4 | — | — | 1994-04-06 | — | — | EP | disclosed |
| WO-1992013092-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING EXPRESSION OF HEMATOPOIETIC GROWTH FACTOR GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| WO-1992013063-A1 | METHODS OF TRANSCRIPTIONALLY MODULATING EXPRESSION OF GROWTH FACTOR GENES AND GROWTH FACTOR RECEPTOR GENES | ONCOGENE SCIENCE, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| EP-0483249-A1 | METHOD OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION AND OF DISCOVERING CHEMICALS CAPABLE OF FUNCTIONING AS GENE EXPRESSION MODULATORS | Oncogene Science, Inc. (US) | 1992-05-06 | — | — | EP | disclosed |
| WO-1991001379-A1 | METHOD OF TRANSCRIPTIONALLY MODULATING GENE EXPRESSION AND OF DISCOVERING CHEMICALS CAPABLE OF FUNCTIONING AS GENE EXPRESSION MODULATORS | ONCOGENE SCIENCE, INC. (US) | 1991-02-07 | — | — | WO | disclosed |
| EP-0108715-A1 | Dibenzazepine carboxamides | CIBA-GEIGY AG (CH) | 1984-05-16 | — | — | EP | disclosed |